Telehealth and Monitoring for Maternal Morbidity
(MOMs-CC Trial)
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment MOMs Chat and Care Study?
Research shows that telehealth strategies, like those used in the MOMs Chat and Care Study, can improve maternal health outcomes by making healthcare more accessible and empowering patients. In low-resource areas, similar telehealth and education programs have successfully reduced barriers to prenatal care, leading to better maternal health.12345
Is telehealth and remote monitoring safe for maternal health?
Telehealth and remote monitoring for maternal health, especially for conditions like postpartum hypertension (high blood pressure after childbirth), have been found to be feasible and acceptable among women and healthcare providers, with early studies suggesting improved outcomes and patient satisfaction.16789
How does the MOMs Chat and Care Study treatment differ from other treatments for maternal morbidity?
The MOMs Chat and Care Study treatment is unique because it uses telehealth and digital tools to provide maternal care, which can extend the reach of healthcare services to women in their everyday lives, especially in areas with limited access to traditional healthcare facilities. This approach leverages technology to improve maternal health outcomes by offering remote monitoring and communication, which is not typically available in standard maternal care.1451011
What is the purpose of this trial?
The purpose of this pragmatic, randomized clinical trial designed to test the effectiveness of an integrated care model approach at two different levels of intensity designed to facilitate timely, appropriate care for high-risk Black and Hispanic/Latina birthing people and reduce risk for severe maternal morbidity (SMM). Eligible Black and Hispanic/Latina birthing people (n = 674) will be recruited and randomized to one of two study arms: MOMs High-Touch (MOMs-HT) vs. MOMs Low-Touch (MOMs-LT). The two study arms will be compared on incidence of SMM at labor and delivery (Aim 1), incidence rate of SMM-related hospitalizations at 1-month and 1-year postpartum (Aim 1a), time to preeclampsia diagnosis and initiation of treatment (Aim 2), change in perceived social support domains (Aim 3), and physical activity trajectories (exploratory Aim 4). Mixed methods will also be used to examine facilitators and barriers to implementation (Aim 5). Findings from this study will help to determine how to feasibly implement an effective and sustainable integrated care approach to address SMM disparities.
Research Team
Stephanie L Fitzpatrick, PhD
Principal Investigator
Northwell Health
Eligibility Criteria
This trial is for high-risk Black birthing individuals to test care models aimed at reducing severe maternal morbidity (SMM). Participants will be randomly assigned to a 'High-Touch' or 'Low-Touch' group, receiving different levels of care intensity.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prenatal Treatment
Participants receive clinical and behavioral health monitoring via chatbot technology and telehealth visits. MOMs-HT includes 12 bi-weekly self-management support telehealth visits during the prenatal period.
Postpartum Follow-up
Participants continue to receive bi-weekly telehealth visits with navigation to clinical, behavioral, and social services up to 6 weeks postpartum.
Extended Follow-up
Participants are monitored for severe maternal morbidity and other outcomes up to 1 year postpartum.
Treatment Details
Interventions
- MOMs Chat and Care Study
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwell Health
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator